Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T S Collins

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|October 20, 2000
MEK inhibition enhances paclitaxel-induced tumor apoptosisJ P MacKeigan, T S Collins, J P Ting
Cancer Immunology, Immunotherapy : CII|May 24, 2000
Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-kappaB- and AP-1-dependent mechanismT S Collins, L F Lee, J P Ting
Clinical and Diagnostic Laboratory Immunology|September 1, 1994
Soluble human complement receptor type 1 inhibits complement-mediated host defenseA J Swift, T S Collins, P Bugelski, et al.
The American Journal of Tropical Medicine and Hygiene|October 28, 1998
Group B streptococcal colonization in a developing country: its association with sexually transmitted disease and socioeconomic factorsT S Collins, M Calderon, R H Gilman, et al.
American Journal of Public Health|December 1, 1993
Neonatal tetanus in Peru: risk assessment with modified enzyme-linked immunosorbent assay and toxoid skin testL Vernacchio, G Madico, M Verastegui, et al.
The Journal of Biological Chemistry|November 4, 1994
Hemolytically inactive C4B complement allotype caused by a proline to leucine mutation in the C5-binding siteR H McLean, G Niblack, B Julian, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|October 20, 2000
MEK inhibition enhances paclitaxel-induced tumor apoptosisJ P MacKeigan, T S Collins, J P Ting
Cancer Immunology, Immunotherapy : CII|May 24, 2000
Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-kappaB- and AP-1-dependent mechanismT S Collins, L F Lee, J P Ting
Clinical and Diagnostic Laboratory Immunology|September 1, 1994
Soluble human complement receptor type 1 inhibits complement-mediated host defenseA J Swift, T S Collins, P Bugelski, et al.
The American Journal of Tropical Medicine and Hygiene|October 28, 1998
Group B streptococcal colonization in a developing country: its association with sexually transmitted disease and socioeconomic factorsT S Collins, M Calderon, R H Gilman, et al.
American Journal of Public Health|December 1, 1993
Neonatal tetanus in Peru: risk assessment with modified enzyme-linked immunosorbent assay and toxoid skin testL Vernacchio, G Madico, M Verastegui, et al.
The Journal of Biological Chemistry|November 4, 1994
Hemolytically inactive C4B complement allotype caused by a proline to leucine mutation in the C5-binding siteR H McLean, G Niblack, B Julian, et al.
Pageof 1